Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

Published 17 hours ago

Source: rss.nytimes.com

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

Enbrel, a once-a-week injection used to treat a variety of autoimmune conditions, first arrived on the market nearly 30 years ago.

Categories

Prices (Fares, Fees and Rates)Inventions and PatentsDrugs (Pharmaceuticals)Health Insurance and Managed CLaw and LegislationRegulation and Deregulation ofState LegislaturesAutoimmune DiseasesInsuranceGeneric Brands and Products

Read Original Article

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

Categories

Related Articles from rss.nytimes.com

Suspect in Palisades Fire Pleads Not Guilty to Setting Blaze

Democrats Block Federal Worker Pay Bill as Shutdown Drags On

Protester Who Played ‘Star Wars’ Song Sues After Arrest in Washington

Musk Attacks NASA Leader Over Threat to Reconsider Lunar Contract

Trump Official Says U.S. Can House Migrants at All of Its Overseas Bases

Trump Calls Off Federal Operation in San Francisco